Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN)

CUSIP: 83548R204

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COM NEW
Shares outstanding
6,190,476
Total 13F shares
7,307,337
Share change
+7,176,449
Total reported value
$2,631,129
Price per share
$0.36
Number of holders
17
Value change
+$2,543,749
Number of buys
11
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 83548R204?
CUSIP 83548R204 identifies SONN - Sonnet BioTherapeutics Holdings, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) as of Q1 2023

As of 31 Mar 2023, Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,307,337 shares. The largest 10 holders included Anson Funds Management LP, Walleye Capital LLC, SABBY MANAGEMENT, LLC, Alyeska Investment Group, L.P., Ayrton Capital LLC, CVI Holdings, LLC, BOOTHBAY FUND MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, and NORTHERN TRUST CORP. This page lists 17 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.